{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:49:55Z","timestamp":1791805795177,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajog.2026.09.007","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:34:32Z","timestamp":1791804872000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myo-inositol to prevent gestational diabetes: \u201cWhat do conflicting trials tell clinicians?\u201d"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4536-6465","authenticated-orcid":false,"given":"Serena","family":"Lecis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"D\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Garzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-9564","authenticated-orcid":false,"given":"Fabio","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2026.09.007_bib1","article-title":"The effect of myo-inositol supplementation on preventing of gestational diabetes mellitus: a systematic review and meta-analysis","author":"Poyantos Leon","year":"2026","journal-title":"AJOG"},{"key":"10.1016\/j.ajog.2026.09.007_bib2","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1021\/jm030071j","article-title":"Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity","volume":"46","author":"Larner","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.ajog.2026.09.007_bib3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/17425255.2020.1828344","article-title":"An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs)","volume":"16","author":"Facchinetti","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ajog.2026.09.007_bib4","article-title":"Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child","volume":"356","author":"Catalano","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.09.007_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41366-020-0596-5","article-title":"High placental inositol content associated with suppressed pro-adipogenic effects of maternal glycaemia in offspring: the GUSTO cohort","volume":"45","author":"Chu","year":"2021","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"10.1016\/j.ajog.2026.09.007_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2023.11.878","article-title":"854 Inositols pathway is altered in placental tissue of obese women","volume":"230","author":"Di Vinci","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.09.007_bib7","doi-asserted-by":"crossref","first-page":"279.e1","DOI":"10.1016\/j.ajog.2018.11.1101","article-title":"Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols","volume":"220","author":"Longo","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.09.007_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109050","article-title":"IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study Group\u2019s criteria","volume":"183","author":"Wang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajog.2026.09.007_bib9","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/GRF.0b013e31815a61d6","article-title":"Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring","volume":"50","author":"Metzger","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.09.007_bib10","article-title":"Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up","volume":"367","author":"Yu","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.09.007_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6692695","article-title":"Factors associated with gestational diabetes mellitus: a meta-analysis","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ajog.2026.09.007_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamainternmed.2021.6373","article-title":"Association of antenatal diet and physical activity-based interventions with gestational weight gain and pregnancy outcomes: a systematic review and meta-analysis","volume":"182","author":"Teede","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajog.2026.09.007_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-084159","article-title":"Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis","volume":"392","author":"Allotey","year":"2026","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.09.007_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s43856-024-00491-1","article-title":"Effective interventions in preventing gestational diabetes mellitus: a systematic review and meta-analysis","volume":"4","author":"Takele","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.ajog.2026.09.007_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","article-title":"Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial","volume":"3","author":"Hanem","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ajog.2026.09.007_bib16","article-title":"Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes","volume":"2","author":"Motuhifonua","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2026.09.007_bib17","series-title":"Gestione della gravidanza ad alto rischio","year":"2023"},{"key":"10.1016\/j.ajog.2026.09.007_bib18","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.3390\/ijms19113342","article-title":"The pathophysiology of gestational diabetes mellitus","volume":"19","author":"Plows","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2026.09.007_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00592-022-02011-w","article-title":"Prevalence of gestational diabetes mellitus in women with a family history of type 2 diabetes in first- and second-degree relatives","volume":"60","author":"Monod","year":"2023","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ajog.2026.09.007_bib20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc12-1371","article-title":"myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study","volume":"36","author":"D\u2019Anna","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2026.09.007_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/AOG.0000000000000958","article-title":"myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial","volume":"126","author":"D\u2019Anna","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.09.007_bib22","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.3109\/14767058.2015.1121478","article-title":"myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial","volume":"29","author":"Santamaria","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2026.09.007_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/dc16-2449","article-title":"The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial","volume":"40","author":"Farren","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2026.09.007_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/14767058.2018.1500545","article-title":"The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial","volume":"33","author":"Celentano","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2026.09.007_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1080\/09637486.2020.1852191","article-title":"myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes\u2014a randomized and open-label, placebo-controlled clinical trial","volume":"72","author":"Vitale","year":"2021","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.ajog.2026.09.007_bib26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2337\/dc20-2515","article-title":"myo-inositol, probiotics, and micronutrient supplementation from preconception for glycemia in pregnancy: NiPPeR international multicenter double-blind randomized controlled trial","volume":"44","author":"Godfrey","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2026.09.007_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050110","article-title":"myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study","volume":"12","author":"Amaefule","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2026.09.007_bib28","first-page":"357","article-title":"The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial","volume":"75","author":"Esmaeilzadeh","year":"2022","journal-title":"Minerva Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.09.007_bib29","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00404-024-07618-8","article-title":"Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial","volume":"310","author":"Asimakopoulos","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2026.09.007_bib30","article-title":"D-chiro inositol supplementation and the occurrence of gestational diabetes: a randomized controlled trial in China","volume":"13","author":"Chen","year":"2024","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.ajog.2026.09.007_bib31","first-page":"1023","article-title":"Role of myo-inositol supplementation in prevention of gestational diabetes mellitus in parturient women at risk","volume":"31","author":"Naheed","year":"2024","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"10.1016\/j.ajog.2026.09.007_bib32","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2214956","article-title":"Treatment of gestational diabetes mellitus diagnosed early in pregnancy","volume":"388","author":"Simmons","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2026.09.007_bib33","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","volume":"95","author":"Croze","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.ajog.2026.09.007_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/17425255.2019.1651839","article-title":"Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors","volume":"15","author":"Garzon","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ajog.2026.09.007_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12916-024-03246-w","article-title":"Impact of preconception and antenatal supplementation with myo-inositol, probiotics, and micronutrients on offspring BMI and weight gain over the first 2 years","volume":"22","author":"Lyons-Reid","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.ajog.2026.09.007_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/1471-0528.70045","article-title":"Maternal myo-inositol intake and congenital heart defects in offspring: a population-based case-control study","volume":"133","author":"Cen","year":"2026","journal-title":"BJOG"},{"issue":"241","key":"10.1016\/j.ajog.2026.09.007_bib37","first-page":"e1","article-title":"Physiological subtypes of gestational glucose intolerance and risk of adverse pregnancy outcomes","volume":"226","author":"Selen","year":"2022","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826004886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826004886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:34:36Z","timestamp":1791804876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937826004886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S0002937826004886"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2026.09.007","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myo-inositol to prevent gestational diabetes: \u201cWhat do conflicting trials tell clinicians?\u201d","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2026.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}